Product Description: Cavutilide (Niferidil) is a class III antiarrhythmic agent that inhibits hERG K+ channel. Cavutilide has the potential for the study of persistent atrial fibrillation[1][2].
Applications: Neuroscience-Neuromodulation
Formula: C22H26FN3O3
References: [1]WHO Drug Information, Vol. 36, No. 2, 2022./[2]Abramochkin DV, et al. Characterization of hERG K+ channel inhibition by the new class III antiarrhythmic drug cavutilide. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):5093-5104.
CAS Number: 1276186-19-6
Molecular Weight: 399.46
Research Area: Cardiovascular Disease
Solubility: 10 mM in DMSO
Target: Potassium Channel